Monash Medical Centre

Futó vizsgálatok

• Még nem toboroz

  AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both

  NCT07931573· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  Evaluation of XYA02 in Patients With Advanced Solid Tumors

  NCT07670312· 1/2. fázis· XYone Therapeutics, Inc· Forrás

• Toboroz

  A Study of GFH276 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors and Pancreatic Ductal Adenocarcinoma (PDAC) Harboring RAS Mutation

  NCT07678593· 1/2. fázis· Genfleet Therapeutics (Shanghai) Inc.· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  NCT07577843· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

  NCT07469891· 1. fázis· Prelude Therapeutics Incorporated· Forrás

• Toboroz

  Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

  NCT07493512· 1. fázis· Amgen· Forrás

• Toboroz

  Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

  NCT07531095· 1. fázis· Amgen· Forrás

• Toboroz

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  NCT07355218· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07258511· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

  NCT07104565· 2. fázis· Incyte Corporation· Forrás

• Fut, nem toboroz

  Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

  NCT07225686· 3. fázis· Amgen· Forrás

• Toboroz

  A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

  NCT07276399· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

  NCT07213674· 3. fázis· Amgen· Forrás

• Toboroz

  A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

  NCT07278336· 1. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

  NCT07226765· 3. fázis· Amgen· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  NCT07059845· 2. fázis· AbbVie· Forrás

• Toboroz

  A Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel

  NCT07149857· 2. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

  NCT07116967· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

  NCT07147348· 1/2. fázis· BioNTech SE· Forrás

• Toboroz

  AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

  NCT06959524· Boston Scientific Corporation· Forrás

• Fut, nem toboroz

  A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

  NCT07005128· 3. fázis· Amgen· Forrás

• Toboroz

  A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  NCT07060807· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

  NCT06963827· 3. fázis· Takeda· Forrás

• Toboroz

  A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

  NCT06944522· 3. fázis· BlueRock Therapeutics· Forrás

• Toboroz

  A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

  NCT06682988· 2. fázis· AbbVie· Forrás

• Toboroz

  Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

  NCT06812715· 2. fázis· Peter MacCallum Cancer Centre, Australia· Forrás

• Fut, nem toboroz

  A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis

  NCT06934226· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC

  NCT06745323· 2. fázis· Amgen· Forrás

• Toboroz

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  NCT06612268· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive Chemotherapy

  NCT06456463· 2. fázis· Stemline Therapeutics, Inc.· Forrás

• Toboroz

  Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

  NCT06750185· 1/2. fázis· BioNTech SE· Forrás

• Toboroz

  International Care Bundle Evaluation in Cerebral Hemorrhage Research

  NCT06429332· 4. fázis· Region Skane· Forrás

• Toboroz

  RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  NCT06798896· 2. fázis· Supernus Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

  NCT06691984· 3. fázis· Amgen· Forrás

• Toboroz

  A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

  NCT06768489· 1. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

  NCT06690775· 2. fázis· TORL Biotherapeutics, LLC· Forrás

• Toboroz

  Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis

  NCT07612280· 1/2. fázis· Jubilant Therapeutics Inc.· Forrás

• Toboroz

  Phase II Study of the Combination of Durvalumab (MEDI4736) (PDL1 Inhibitor) and Olaparib (PARP Inhibitor) in Advanced Cholangiocarcinoma After Initial Chemotherapy and Durvalumab (BIL-PPP)

  NCT06441747· 2. fázis· Australasian Gastro-Intestinal Trials Group· Forrás

• Fut, nem toboroz

  A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  NCT06461897· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT06508658· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

  NCT06332534· 3. fázis· AbbVie· Forrás

• Még nem toboroz

  Australasian Nanoparticle-mediated Magnetically Enhanced Diffusion for Ischemic Stroke

  NCT06495671· University of Melbourne· Forrás

• Fut, nem toboroz

  A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression

  NCT06365853· 2. fázis· AbbVie· Forrás

• Toboroz

  A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

  NCT06100744· 3. fázis· AbbVie· Forrás

• Fut, nem toboroz

  Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab

  NCT06211036· 3. fázis· Amgen· Forrás

• Toboroz

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· 3. fázis· Kartos Therapeutics, Inc.· Forrás

• Toboroz

  Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

  NCT05892510· 2/3. fázis· University of Melbourne· Forrás

Showing 50 of 125.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Petefészekrák7 toboroz
• Prosztatarák6 toboroz
• Stroke (szélütés)5 toboroz
• Tüdőrák5 toboroz
• Máj- és epeúti rák4 toboroz
• Mielóma multiplex4 toboroz
• Crohn-betegség3 toboroz
• Fej-nyaki daganatok3 toboroz
• Gyomor- és nyelőcsőrák3 toboroz
• Hasnyálmirigyrák3 toboroz
• Méhtestrák3 toboroz
• Mieloproliferatív neopláziák3 toboroz
• Vastagbélrák3 toboroz
• Colitis ulcerosa2 toboroz
• Gyermekkori daganatok2 toboroz
• Koszorúér-betegség2 toboroz
• Krónikus limfoid leukémia (CLL)2 toboroz
• Melanóma2 toboroz
• Pikkelysömör2 toboroz
• Tripla negatív emlőrák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Akut mieloid leukémia (AML)1 toboroz
• Amiloidózis1 toboroz
• Arthritis psoriatica1 toboroz
• Áttétes emlőrák1 toboroz
• Cisztás fibrózis1 toboroz
• Epilepszia1 toboroz
• Hólyagrák1 toboroz
• Idiopátiás tüdőfibrózis1 toboroz
• IgA-nefropátia1 toboroz
• Immune thrombocytopenia (ITP)1 toboroz
• Köpenysejtes limfóma1 toboroz
• Krónikus mieloid leukémia (CML)1 toboroz
• Krónikus vesebetegség1 toboroz
• Lupus (SLE)1 toboroz
• Méhnyakrák1 toboroz
• Parkinson-kór1 toboroz
• Peripheral artery disease1 toboroz
• Sarlósejtes vérszegénység1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Toboroz

  Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

  NCT06226805· 2. fázis· Basking Biosciences, Inc.· Forrás

• Leállították

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· 2. fázis· Pliant Therapeutics, Inc.· Forrás

• Leállították

  Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

  NCT06068868· 1. fázis· AbbVie· Forrás

• Toboroz

  Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

  NCT06051617· 3. fázis· Gilead Sciences· Forrás

• Lezárult

  A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)

  NCT05558696· 2. fázis· Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)· Forrás

• Lezárult

  A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

  NCT05975073· 1/2. fázis· Amgen· Forrás

• Leállították

  A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

  NCT05317078· 1. fázis· Amgen· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

  NCT05669599· 2. fázis· Amgen· Forrás

• Lezárult

  A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

  NCT05174221· 1. fázis· Takeda· Forrás

• Lezárult

  The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

  NCT05162586· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· 2. fázis· Calliditas Therapeutics Suisse SA· Forrás

• Lezárult

  A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

  NCT05002127· 2/3. fázis· ALX Oncology Inc.· Forrás

• Lezárult

  Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

  NCT05041257· 2. fázis· AbbVie· Forrás

• Lezárult

  A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

  NCT04779307· 3. fázis· Takeda· Forrás

• Lezárult

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· 2. fázis· Gilead Sciences· Forrás

• Lezárult

  Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder

  NCT04745026· 2. fázis· Jazz Pharmaceuticals· Forrás

• Leállították

  Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis

  NCT04807972· 1. fázis· AbbVie· Forrás

• Lezárult

  A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

  NCT04771273· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma

  NCT04763408· Eisai Inc.· Forrás

• Lezárult

  Alleviate-HF-2 Study

  NCT04838353· Alleviant Medical, Inc.· Forrás

• Lezárult

  Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

  NCT04744831· 2. fázis· Daiichi Sankyo· Forrás

• Lezárult

  A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

  NCT04657224· 1. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

  NCT04472429· 3. fázis· Incyte Corporation· Forrás

• Lezárult

  A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

  NCT04451772· 2. fázis· AbbVie· Forrás

• Leállították

  Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

  NCT04365868· 2/3. fázis· Galectin Therapeutics Inc.· Forrás

• Lezárult

  Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).

  NCT04303780· 3. fázis· Amgen· Forrás

• Lezárult

  A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

  NCT04083235· 3. fázis· Ipsen· Forrás

• Lezárult

  A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

  NCT04138277· 3. fázis· Amicus Therapeutics· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis

  NCT04169373· 3. fázis· AbbVie· Forrás

• Lezárult

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· 3. fázis· Amgen· Forrás

• Lezárult

  ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)

  NCT03685448· 2. fázis· Australian and New Zealand Urogenital and Prostate Cancer Trials Group· Forrás

• Lezárult

  A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

  NCT03900598· 1. fázis· Janssen Research & Development, LLC· Forrás

• Leállították

  Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

  NCT03646123· 2. fázis· Seagen Inc.· Forrás

• Lezárult

  Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

  NCT03710876· 3. fázis· Ferring Ventures Limited· Forrás

• Lezárult

  Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.

  NCT05565430· Monash Medical Centre· Forrás

• Lezárult

  Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

  NCT03377491· 3. fázis· NovoCure Ltd.· Forrás

• Lezárult

  Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

  NCT03473223· 3. fázis· CSL Behring· Forrás

• Lezárult

  A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma

  NCT03274492· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

  NCT03072238· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· 3. fázis· Alfasigma S.p.A.· Forrás

• Lezárult

  Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)

  NCT02910583· 2. fázis· Pharmacyclics LLC.· Forrás

• Lezárult

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· 3. fázis· Pfizer· Forrás

• Lezárult

  Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

  NCT02273375· 3. fázis· Canadian Cancer Trials Group· Forrás

• Lezárult

  Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia

  NCT02242942· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Pfizer· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Brain aneurysm6 munka · 0 vizsgálat
• ANCA-asszociált vasculitis6 munka · 0 vizsgálat